BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
Non-exclusive Framework Agreement (FAG) for the supply to the NHS Supply Chain customer base via the E-Direct Route. Product range to include, but not limited to stimulation of; Deep Brain, Spinal Cord, Sacral Nerve, Vagal Nerve, Dorsal Route Ganglion, Peripheral Nerve, Radio Frequency Pain Management, Intrathecal Brug Delivery Pumps, Dorsal Ramus Medial Branch nerve and other devices that provide nerve stimulation or pain management that meet the requirements of users and patients. The FAG will provide access to Neuromodulation Devices/Consumables that are associated with Neuromodulation procedures.
Precise quantities are unknown. It is anticipated that initial expenditure will be in the region of £92,000,000.00 the term of FAG, however this is approximate only and the values may vary depending on the requirements of those bodies purchasing under the FAG. The estimated value over the total FAG term (including any extension options) is £392,000,000.00.
Additional information:
Located in attachments is a Daft version of the Framework Agreement
| Supplier | Identifier | Award Value | Cross-References |
|---|---|---|---|
| Abbott Medical U.K. Ltd. | 02423907 | ~£392,000,000 estimated from lot values | - |
| Avanos Medical UK Limited | 09051011 | ~£392,000,000 estimated from lot values | - |
| Axonics Modulation Technologies UK Ltd | 09622653 | ~£392,000,000 estimated from lot values | - |
| Boston Scientific Ltd | 02729626 | ~£392,000,000 estimated from lot values | - |
| BVM MEDICAL LTD | 02403695 | ~£392,000,000 estimated from lot values | - |
| Charco Neurotech | 12028625 | ~£392,000,000 estimated from lot values | - |
| ElectroCore UK Ltd. | 09432721 | ~£392,000,000 estimated from lot values | - |
| Far From Surgical Solutions | - | ~£392,000,000 estimated from lot values | - |
| Flow Neuroscience | - | ~£392,000,000 estimated from lot values | - |
| Freedom Neuro BV | - | ~£392,000,000 estimated from lot values | - |
| Inomed Neurocare Limited | 11102850 | ~£392,000,000 estimated from lot values | - |
| Inspire Medical Systems | - | ~£392,000,000 estimated from lot values | - |
| LivaNova UK Limited | 05164784 | ~£392,000,000 estimated from lot values | - |
| Mainstay Medical; ReActiv8 | - | ~£392,000,000 estimated from lot values | - |
| Medtronic Limited | 01070807 | ~£392,000,000 estimated from lot values | LOBBYIST Political Lobbying & Media Relations Limited (7 quarters) |
| Nevro Medical LTD / Nevro Corp. | - | ~£392,000,000 estimated from lot values | - |
| Nyxoah SA | - | ~£392,000,000 estimated from lot values | - |
| Optimus Medical Ltd | 08254822 | ~£392,000,000 estimated from lot values | - |
| P14 Medical ltd/TA Platform 14 | - | ~£392,000,000 estimated from lot values | - |
| PHAGENESIS LTD | 06308699 | ~£392,000,000 estimated from lot values | - |
| Polar Medical Ltd | 09895845 | ~£392,000,000 estimated from lot values | - |
| Precisis GmbH | - | ~£392,000,000 estimated from lot values | - |
| Saluda Medical | - | ~£392,000,000 estimated from lot values | - |
Government spending data: These suppliers have received £671,560,621 in 15,394 payments (over £25k) from NHS Supply Chain (DHSC-funded), Manchester University NHS Foundation Trust, Guy's and St Thomas' NHS FT, Maidstone and Tunbridge Wells NHS Trust, Department of Health and Social Care and 11 more public bodies (2018-04-05 to 2026-03-31).